Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors

J Nutr Biochem. 2016 Jul:33:145-53. doi: 10.1016/j.jnutbio.2016.03.016. Epub 2016 Apr 1.

Abstract

The etiology of cardiovascular disease (CVD) is impacted by multiple modifiable and non-modifiable risk factors including dietary choices, genetic predisposition, and environmental exposures. However, mechanisms linking diet, exposure to pollutants, and CVD risk are largely unclear. Recent studies identified a strong link between plasma levels of nutrient-derived Trimethylamine N-oxide (TMAO) and coronary artery disease. Dietary precursors of TMAO include carnitine and phosphatidylcholine, which are abundant in animal-derived foods. Dioxin-like pollutants can upregulate a critical enzyme responsible for TMAO formation, hepatic flavin containing monooxygenase 3 (FMO3), but a link between dioxin-like PCBs, upregulation of FMO3, and increased TMAO has not been reported. Here, we show that mice exposed acutely to dioxin-like PCBs exhibit increased hepatic FMO3 mRNA, protein, as well as an increase in circulating levels of TMAO following oral administration of its metabolic precursors. C57BL/6 mice were exposed to 5μmol PCB 126/kg mouse weight (1.63mg/kg). At 48h post-PCB exposure, mice were subsequently given a single gavage of phosphatidylcholine dissolved in corn oil. Exposure to 5 μmole/kg PCB 126 resulted in greater than 100-fold increase in FMO3 mRNA expression, robust induction of FMO3 protein, and a 5-fold increase in TMAO levels compared with vehicle treated mice. We made similar observations in mice exposed to PCB 77 (49.6mg/kg twice); stable isotope tracer studies revealed increased formation of plasma TMAO from an orally administered precursor trimethylamine (TMA). Taken together, these observations suggest a novel diet-toxicant interaction that results in increased production of a circulating biomarker of cardiovascular disease risk.

Keywords: Cardiovascular disease; FMO3; Nutrition; PCB toxicity; TMAO.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Oral
  • Animals
  • Atherosclerosis / blood
  • Atherosclerosis / etiology*
  • Atherosclerosis / metabolism
  • Biomarkers / blood
  • Choline / administration & dosage
  • Choline / metabolism*
  • Deuterium
  • Dietary Fats / metabolism
  • Environmental Pollutants / administration & dosage
  • Environmental Pollutants / toxicity*
  • Enzyme Induction / drug effects
  • Food-Drug Interactions
  • Liver / drug effects*
  • Liver / enzymology
  • Liver / metabolism
  • Male
  • Methylamines / administration & dosage
  • Methylamines / blood*
  • Methylamines / metabolism
  • Mice, Inbred C57BL
  • Oxygenases / chemistry
  • Oxygenases / genetics
  • Oxygenases / metabolism*
  • Phosphatidylcholines / administration & dosage
  • Phosphatidylcholines / metabolism
  • Polychlorinated Biphenyls / administration & dosage
  • Polychlorinated Biphenyls / toxicity*
  • Random Allocation
  • Up-Regulation / drug effects

Substances

  • Biomarkers
  • Dietary Fats
  • Environmental Pollutants
  • Methylamines
  • Phosphatidylcholines
  • Deuterium
  • Polychlorinated Biphenyls
  • Oxygenases
  • dimethylaniline monooxygenase (N-oxide forming)
  • trimethyloxamine
  • trimethylamine
  • Choline
  • 3,4,5,3',4'-pentachlorobiphenyl